The issue of burying people in concrete graves in Lango BY NELLY NELSONS OTTO LIRA The issue of burying people in concrete graves has generated a lot of debate among the cultural leaders in Lango where the Tekwaro Lango Paramount Chief (Won Nyaci) Eng Dr Michael Moses Odongo-Okune has asked for science-guided consensus. Odongo-Okune, also…
Asian Stocks in Flux: A Rollercoaster Ride The Tale of Two Markets Asian stock markets commenced the week with divergent performances. While Japan’s Nikkei showed resilience, bouncing back after enduring its most challenging week this year, Hong Kong’s stocks weren’t as fortunate. The uncertainty surrounding China Evergrande Group’s protracted debt restructuring initiative ignited a fresh…
Goldman Sachs on US Equities The Worst Seasonal Equity Period Goldman Sachs recently made a bold statement regarding US equities, suggesting that we are currently in the middle of the worst seasonal equity period of the year. According to their analysis, the median SPX return for the last 10 out of 11 days in September…
ZEGOCLOUD Shines at TechSparks 2023 in Bengaluru A Recap of the Event SINGAPORE–(BUSINESS WIRE)–#appdev—ZEGOCLOUD, a leading global cloud communication service provider, proudly concludes its successful participation at TechSparks 2023 in Bengaluru, India’s premier startup-tech event during September 21-23. TechSparks, now in its 14th year, is a coveted platform for startups, enterprises, investors, and policymakers to…
Breaking News: Leqembi Intravenous Infusion (Lecanemab) Receives Approval for Alzheimer’s Treatment in Japan Description: TOKYO and CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody LEQEMBI® Intravenous Infusion (lecanemab) has been approved for the treatment of Alzheimer’s Disease in Japan….
GUIYANG, China, Sept. 24, 2023 A tourist’s memorable experience in Guiyang Recently, a news report by Huanqiu.com highlighted the story of Ma Xiaohui, a tourist in Guiyang, who shared her fascinating experience after taking the Chengdu–Guiyang high-speed train to the city. Ma Xiaohui was thoroughly impressed by the seamless connectivity and convenience offered by Guiyang’s…
Exciting News from AffaMed Therapeutics A Global Leader in Biotechnology SHANGHAI, Sept. 25, 2023 /PRNewswire/ — AffaMed Therapeutics (“AffaMed”), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychiatric disorders, today announced that China’s National Medical Products Administration has…
The Importance of Patience in Monetary Policy Bank of France President Francois Villeroy de Galhau’s Stance Witty, conversational, and delightfully offbeat Last week, Bank of France President Francois Villeroy de Galhau made headlines when he announced that he is not in a hurry to raise rates further. In a conversation with Bloomberg, he emphasized the…
